Our institute stands as a global leader in the surgical treatment of infective endocarditis. With an experience encompassing over 4,000 patients to date, we have achieved remarkable outcomes. Over the past decade, our hospital’s mortality rate has remained between 1.5% to 2.0%, with a recurrence rate of less than 1%. Our greatest accomplishments lie in treating patients with concomitant involvement of the central nervous system, lungs, and kidneys.

We have successfully implemented highly effective treatment methods for infective endocarditis caused by multidrug-resistant pathogens. These advanced treatment approaches have been integrated into our practice, ensuring optimal care for our patients.